Surgery for downstaging chemotherapy
Approximately 15% of patients with initially inoperable liver metastases from bowel cancer are ultimately resected after neo-adjuvant chemotherapy. The treatment includes Oxaliplatin or Irinotecan, in combination with 5-Fluorouracil. Monoclonal antibodies, such as anti-VEGF or anti-EGFR are available to private patients and have been associated with a better response rate than conventional regimens. Recruitment into clinical trials is also possible in collaboration with our oncologists.
For more information about surgery for downstaging chemotherapy at the Royal Free Private Patients Unit, please call or email on:
Tel: 020 7317 7751